What this study is
The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes (T2D).
What's being tested
- CGM
Intervention · DEVICE
The CGM sensor is worn on the back of the arm and glucose levels are recorded continuously but levels are not shown on the participant's phone app in phase A.
Study details
- Official title
- Continuous Glucose Monitoring (CGM) in Prediabetes With Health Education Videos
- Sponsor
- David S Black, PhD
- Conditions
- Prediabetes
- Enrolling
- 50 people
- Starts
- 2026-02-26
- Est. completion
- 2027-03-30
- Design
- Open-label, sequential groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 35 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- 35 years of age or older
- Willingness to wear CGM sensor
- Prediabetes by finger prick blood A1C% or fasting glucose
- Centers for Disease Control and Prevention (CDC) prediabetes risk test score of 5 or higher or recent prediabetes diagnosis from physician
You can't join if
- Diagnosed with any disorder that interferes with glucose
- Influential medical disorder/event affecting ability to participate in study
- Incompatible smartphone device not pairing with Dexcom G6 app
- Currently pregnant
- Previously participated in other Continuous Glucose Monitoring studies
- Having a planned trip outside California in the following 2 months
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openSouthern California Center for Latino Health (SCCLH)
Los Angeles, California, United States
Recruiting
Study team
Sponsor
David S Black, PhD
Study ID UP-23-01001(b)
Principal investigator
David S Black, PhD MPH
University of Southern California Keck School of Medicine
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.